Short‐Course Therapy for Right‐Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
A prospective, randomized clinical trial among drug abusers was conducted to assess the efficacy and safety of a short course of a combination of a glycopeptide (vancomycin or teicoplanin) and gentamicin compared with a combination of cloxacillin and gentamicin for treatment of right-side endocarditis caused by Staphylococcus aureus. Therapeutic success was significantly more frequent with cloxacillin than with a glycopeptide. No adverse effects were noted among patients in the cloxacillin group. A 14-day course of vancomycin or teicoplanin plus gentamicin is ineffective in this instance because it is associated with a high rate of clinical and microbiological failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in IDUs with uncomplicated right-sided S aureus IE (no evidence of renal failure, extrapulmonary metastatic infections, aortic or mitral valve involvement, meningitis, or infection by MRSA), combined short-course (2 weeks) β-lactam plus aminoglycoside therapy was highly effective in several studies.91,92,148”
In the citing paper
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.148”
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Clinical Microbiology Procedures Handbook
(2016) · ASM Press eBooks · doi:10.1128/9781555818814 · Cited by 2,240
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
Rybak, M. J., Albrecht, L. M., Boike, S. C., & Chandrasekar, P. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.679 · Cited by 388
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214 · cited 2×
“aureus endocarditis, whereas 47 of 50 patients with methicillin-susceptible isolates were cured with a 2-week course of nafcillin-tobramycin therapy [1].”
BackgroundRibera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187 · cited 1×
“Moreover, a recent study has confirmed similar results for patients who received 2 weeks of cloxacillin monotherapy, which indicates that adding an aminoglycoside may not be necessary because it does not provide any therapeutic advantage [2].”
ResultGilbert, D. N., Wood, C. A., & Kimbrough, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.79 · Cited by 110
Mild Nephrotoxicity Associated With Vancomycin Use
Downs, N. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080053013 · Cited by 102
Greenberg, R. N. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2392 · Cited by 87
Research works printed but not linked: 2
- Anhalt JP, 1991, DC: American Society for Microbiology, 1192
- Griffin J, 1992, DC: American Society for Microbiology, 5, 17
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
“, vancomycin and teicoplanin) than for those receiving antistaphylococcal penicillins (101, 105).”
BackgroundBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.(148) These glycopeptides may be less effective because of limited bactericidal activity, poor penetration into vegetations,…”
ResultGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
“, 2001 (148) Is a short course of glycopeptide (vancomycin or teicoplanin) and gentamicin as effective as combination cloxacillin and gentamicin for treatment of right-sided NVE caused by methicillin-sensitive S aureus? Adult IVDUs with right-sided NVE caused by MSSA Glycopeptide therapy is inferior to cloxacillin”
BackgroundGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
“In vitro data [10–12] and limited clinical data [12–17] suggest that vancomycin may be less satisfactory than b-lactam antibiotics for the treatment of MSSA.”
BackgroundSvetitsky, S., Leibovici, L., & Paul, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00341-09 · Cited by 275
Clinical management of Staphylococcus aureus bacteraemia
Thwaites, G. E., Edgeworth, J. D., Gkrania-Klotsas, E., Kirby, A., Tilley, R., Török, M. E., Walker, S., Wertheim, H. F., Wilson, P., & Llewelyn, M. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70285-1 · Cited by 261
Schweizer, M. L., Furuno, J. P., Harris, A. D., Johnson, J. K., Shardell, M. D., McGregor, J. C., Thom, K. A., Cosgrove, S. E., Sakoulas, G., & Perencevich, E. N. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-279 · Cited by 254
“Additionally, three more studies compared vancomycin to beta-lactam antibiotics among patients with endocarditis or pneumonia and found that those who received vancomycin had worse patient outcomes [28-30].”
ResultUpdate on Infective Endocarditis
Bashore, T. M., Cabell, C., & Fowler, Jr. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 227
Infective endocarditis in intravenous drug abusers and HIV-1 infected patients
Miró, J. M., del Rı́o, A., & Mestres, C. A. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00008-3 · Cited by 158
“It is important to remember that people who are addicted to drugs with MSSA right-sided IE treated with vancomycin or teicoplanin combined with an aminoglycoside for 2 weeks [70,73] or given alone for 4 weeks [72,78] have an unacceptable failure rate.”
BackgroundMethodInfluentialStaphylococcus aureusbacteraemia and endocarditis – epidemiology and outcome: a review
Ásgeirsson, H., Thalme, A., & Weiland, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1392039 · Cited by 163
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 152
Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients
Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir063 · Cited by 147
“This regimen is supported by several clinical trials including RCTs, none of which were planned to compare treatment durations [44–48].”
Falagas, M. E., Matthaiou, D. K., & Bliziotis, I. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl044 · Cited by 145
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Goldstein, E. J. C., & Proctor, R. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525536 · Cited by 138
Elliott, T. S. J., Foweraker, J., Gould, F. K., Perry, J. D., & Sandoe, J. A. T. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh474 · Cited by 137
Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients
Miró, J. M., del Río, A., & Mestres, C. A. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00025-0 · Cited by 150
“Table 6 summarizes the studies published between 1988 and 2001 [74–79] with a 2-week course of nafcillin or cloxacillin plus an aminoglycoside (usually gentamicin) for the therapy of non-complicated right-sided MSSA endocarditis in IVDAs.”
BackgroundResultInfluentialNative valve right sided infective endocarditis
Akinosoglou, K., Apostolakis, E. E., Marangos, M. N., & Pasvol, G. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.01.010 · Cited by 136
“Glycopeptides such as vancomycin appear to be inferior to antistaphylococcal penicillins for MSSA, in terms of efficacy, safety and microbiological relapse [82,83].”
BackgroundTeicoplanin versus vancomycin for proven or suspected infection
Cavalcanti, A. B., Gonçalves, A., Almeida, C. S., Bugano, D. D. G., & Silva, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007022.pub2 · Cited by 140
Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know
Vandecasteele, S. J., Boelaert, J. R., & Vriese, A. S. D. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01590309 · Cited by 141
“bacteremia, endocarditis, and pneumonia (109-114).”
Combination Antibiotic Therapy for Infective Endocarditis
Le, T., & Bayer, A. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367661 · Cited by 117
“[40] compared short-course therapy for right-side S.”
Tsuji, B. T., & Rybak, M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2735-2745.2005 · Cited by 113
“Clinical investigations have examined the potential for synergy employing a combination of gentamicin and vancomycin and report mixed results (1, 12, 16, 21, 25, 28, 35, 44).”
BackgroundLaPlante, K. L., & Woodmansee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00134-09 · Cited by 110
“This has been observed in clinical studies (16) and in vitro studies (34) with vancomycin, but to our knowledge, this has not yet been observed with daptomycin.”
ResultLodise, T. P., McKinnon, P. S., Levine, D. P., & Rybak, M. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-07 · Cited by 109
Barton, M., Hawkes, M., MOORE, D. L., Conly, J. M., Nicolle, L. E., Allen, U., Boyd, N., Embreé, J., Horne, L. V., Saux, N. L., et al. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/971352 · Cited by 103
Rose, W. E., Leonard, S. N., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00102-08 · Cited by 90
“aureus infections have produced conflicting results (5, 10).”
Role of aminoglycosides in the treatment of bacterial endocarditis
Graham, J., & Gould, F. K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.437 · Cited by 81
“Short-course therapy is less successful with glycopeptides, even in combination with an aminoglycoside.(52) If aminoglycosides are to be used in non-drug users, the shorter duration and lower dose recommended by the AHA would seem appropriate.”
BackgroundLi, J. Z., Willke, R. J., Rittenhouse, B., & Rybak, M. J. (2003) · Surgical Infections · doi:10.1089/109629603764655290 · Cited by 78
“Studies also suggest that vancomycin’s efficacy in methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia and MSSA endocarditis may be lower than that of b -lactam agents [24,29–32].”
Infective Endocarditis in Persons Who Use Drugs
Schranz, A. J., & Barocas, J. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.06.004 · Cited by 72
Shelburne, S. A., Musher, D. M., Hultén, K. G., Ceasar, H., Lu, M. Y., Bhaila, I., & Hamill, R. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4016-4019.2004 · Cited by 75
Infective endocarditis in intravenous drug abusers
Miró, J. M., Moreno, A., & Mestres, C. A. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0007-9 · Cited by 68
Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 69
Saunderson, R. B., Gouliouris, T., Nickerson, E. K., Cartwright, E. J. P., Kidney, A., Aliyu, S. H., Brown, N. M., Limmathurotsakul, D., Peacock, S. J., & Török, M. E. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.05.026 · Cited by 68
“These included: (a) identification and removal of a removable focus of infection [8,26]; (b) performing repeat blood cultures at 48 to 96 hours [27]; (c) performing an echocardiogram [27,28]; (d) use of β-lactam therapy for methicillin-susceptible SAB [29,30]; (e) treatment of uncomplicated infection with 14 days of i…”
BackgroundSwedish guidelines for diagnosis and treatment of infective endocarditis
Westling, K., Aufwerber, E., Ekdahl, C., Friman, G., Gårdlund, B., Julander, I., Olaison, L., Olesund, C., Rundström, H., Snygg‐Martin, U., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534517 · Cited by 66
“Uncomplicated(1) Cloxacillin and 2 A III [50] Gentamicin 2 A III [51] Complicated Cloxacillin 4 6 A III Pc allergy type I Vancomycin 4 A III Pc allergy not type II Cefuroxime 4 A III [52]”
BackgroundKuti, J. L., Kiffer, C. R. V., Mendes, C. M. F., & Nicolau, D. P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01885.x · Cited by 64
“Furthermore, standard glycopeptide doses have been demonstrated to be inferior to b-lactams for the treatment of serious infections with methicillin-susceptible staphylococci [21].”
BackgroundInfective endocarditis: trends, surgical outcomes, and controversies
Jamil, M., Sultan, I. S., Gleason, T. G., Navid, F., Fallert, M., Suffoletto, M. S., & Kilic, A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.45 · Cited by 64
“IE from Methicillin Sensitive Staphylococcus Aureus (MSSA) responds better to oxacillin than vancomycin, indicating the need for de-escalation of antibiotics once the organism is identified (20).”
BackgroundEpidemiology and antibiotic treatment of infective endocarditis: an update
Hoen, B. (2006) · Heart · doi:10.1136/hrt.2005.072595 · Cited by 67
Pragman, A. A., Kuskowski, M. A., Abraham, J. M., & FILICE, G. A. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318255d67c · Cited by 51
Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
Bergin, S. P., Holland, T. L., Fowler, V. G., & Tong, S. Y. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5001 · Cited by 50
[Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].
Mensa, J., Barberán, J., Llinares, P., Picazo, J. J., Bouza, E., Álvarez-Lerma, F., Borges, M. D. S., Serrano, R., León, C., Guirao, X., et al. (2008) · PubMed · Cited by 65
Yamaoka, T. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-007-0521-z · Cited by 49
A comparison of different antibiotic regimens for the treatment of infective endocarditis
Martí-Carvajal, A. J., Dayer, M., Conterno, L. D. O., Garay, A. G. G., & Martí-Amarista, C. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880.pub3 · Cited by 40
New Perspectives of Infections in Cardiovascular Disease
Fong, I. W. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788166679 · Cited by 36
Esposito, S., Esposito, I., & Leone, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks277 · Cited by 36
A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients
Solomkin, J. S., BJORNSON, H. S., Caínzos, M., Dellinger, E. P., Dominioni, L., Eidus, R., Faist, E., Leaper, D. J., Lee, J. T., Lipsett, P. A., et al. (2003) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.03.006 · Cited by 35
“[26] Fortun J, Navas E, Martinez-Beltran J, et al.”
BackgroundA comparison of different antibiotic regimens for the treatment of infective endocarditis
Martí-Carvajal, A. J., Dayer, M., Conterno, L. D. O., Garay, A. G. G., Martí-Amarista, C. E., & Simancas‐Racines, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880.pub2 · Cited by 35
Active infective endocarditis: Clinical characteristics and factors related to hospital mortality.
Rostagno, C., Rosso, G., Puggelli, F., Gelsomino, S., Braconi, L., Montesi, G. F., Romagnoli, S., Stefàno, P., & Gensini, G. F. (2010) · PubMed · Cited by 35
Shah, N. P., Reddy, P., Paladino, J. A., McKinnon, P. S., Klepser, M. E., & Pashos, C. L. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003638 · Cited by 30
New agents for Staphylococcus aureus endocarditis
Drees, M. L., & Boucher, H. W. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328010683e · Cited by 32
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 38
Leonard, S. N., Vidaillac, C., & Rybak, M. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01544-08 · Cited by 27
“The theoretical benefit of combination with an aminoglycoside is early, rapid reduction in the organism burden, and therefore, it is done in spite of scant clinical evidence (4, 9).”
BackgroundHabib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Benedetto, U., Spadaccio, C., Gentile, F., Moon, M. R., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3880 · Cited by 25
“Over the past 20 years 7 RCT were published on antibiotic treatment (65-70), but only one RCT (26) investigated the comparison between medical therapy and early surgery within 48 hours.”
BackgroundEndocarditis in the setting of HIV infection.
Valencia, E., & Miró, J. M. (2004) · PubMed · Cited by 25
Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era?
Nathwani, D., & Tillotson, G. S. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00046-3 · Cited by 25
“[14] Fortun J, Navas E, Martinez-Beltran J, et al.”
BackgroundMurray, B. E., & Nannini, E. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00031-x · Cited by 26
New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus
Bouza, E. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03091.x · Cited by 29
Bland, C. M., Porr, W. H., Davis, K. A., & Mansell, K. B. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181efb5b1 · Cited by 22
Cecchi, E., Imazio, M., Tidu, M., Forno, D., Rosa, F. G. D., Conte, I. D., Preziosi, C., Lipani, F., & Trinchero, R. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000260824.14596.86 · Cited by 22
The Difference between Adequate and Appropriate Antimicrobial Treatment
Siempos, I. Ι., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Infectious Diseases · doi:10.1086/527038 · Cited by 21
Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review
Yung, D. E., Kottachchi, D., Neupane, B., Haider, S., & Loeb, M. B. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm324 · Cited by 20
“In terms of uncomplicated RSE (i.e. MSSA and IVDUs), three of six patients versus one of four Studies comparing single therapies Greenman et al.35 intervention 16 0 NA 0.25 (0.031–1.99)control 16 0 Studies comparing combination to single therapy Ribera et al.31 intervention 36 2 2.11 (0.20–22.29) 1.31 (0.38–4.53) cont…”
BackgroundMethodResultInfluentialRapid decrease of free vancomycin in dense staphylococcal cultures
Ekdahl, C., Hanberger, H., Hällgren, A., Nilsson, M., Svensson, E., & Nilsson, L. E. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0011-0 · Cited by 16
Management of infective endocarditis
BMJ Publishing Group Ltd (2002) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2002.40426 · Cited by 15
Role of intravenous cloxacillin for inpatient infections
Bru, J. P., & Garraffo, R. (2012) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.10.015 · Cited by 13
Clinical Guideline for the Diagnosis and Treatment of Cardiovascular Infections
The Korean Society of Infectious Diseases, Korean Society for Chemotherapy, The Korean Society of Cardiology, & The Korean Society for Thoracic and Cardiovascular Surgery (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.2.129 · Cited by 13
Gold, H. S., & Pillai, S. K. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.008 · Cited by 17
Romero‐Gómez, M. P., Cendejas‐Bueno, E., García‐Rodríguez, J., & Mingorance, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3086-5 · Cited by 12
Seng, P., Amrane, S., Million, M., & Stein, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.004 · Cited by 12
Teicoplanine par voie sous-cutanée chez l’enfant présentant une endocardite infectieuse
Carpentier, E., Roméo, B., Samad, Y. E., Geslin-Lichtenberger, L., Maingourd, Y., & Tourneux, P. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2013.04.019 · Cited by 11
“En particulier, des doses faibles ou un traitement par teicoplanine seule pourraient être associés à des taux élevés de récidive, autour de 30 % [6,13,14].”
BackgroundBoumis, E., Gesu, G. P., Menichetti, F., Ranieri, V. M., Rinaldi, M., Suter, F., Nicastri, E., Lauria, F., Carosi, G., Moroni, M., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.006 · Cited by 12
“In the study by Fortún et al.(14) (GRADE score 2), patients with right-sided S.”
InfluentialA Case of Amoxicillin-Induced Meningitis
Whyte, C. A., Shivdat-Nanhoe, R., & Kramer, P. (2008) · Clinical Infectious Diseases · doi:10.1086/527039 · Cited by 11
Leibovici, L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl143 · Cited by 8
Skin and Soft Tissue Infections
Stryjewski, M. E., Nannini, E. C., & Corey, G. R. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch19 · Cited by 7
Winston, L. G., Deck, D. H., & Bolger, A. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50085-8 · Cited by 7
New therapeutic approach for the treatment for staphylococcal bacteremia and sepsis
Борисович, Б. В. (2014) · Epidemiology and Infectious Diseases · doi:10.17816/eid40824 · Cited by 5
Medical treatment of endocarditis
Abrutyn, E., Cabell, C. H., Fowler, V. G., Hoen, B., Miró, J. M., Mestres, C. A., Sexton, D. J., & Corey, G. R. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0043-y · Cited by 5
Delahaye, F., Vandenesch, F., Hoen, B., LOIRE, R., & Delahaye, J.-P. (2006) · EMC - Cardiologie · doi:10.1016/s1166-4568(06)43686-x · Cited by 5
Soriano, À., & Mensa, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir305 · Cited by 5
“This information is important because the most likely reason for the worse outcome in SABG is the lower efficacy of glycopeptides [15, 16].”
Background26 Miscellaneous antibacterial drugs
Imhof, A., & Laffer, R. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29026-3 · Cited by 4
Bashore, T. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4860-0.00025-6 · Cited by 4
Antibiotic therapy for treatment of infective endocarditis
Martí-Carvajal, A. J., Conterno, L. D. O., Hidalgo, R., Kwong, J. S., Georgoulas, P., & Salanti, G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880 · Cited by 4
Treatment of intra-abdominal and skin and soft tissue infections: The role of the glycylcyclines
Homer‐Vanniasinkam, S. (2006) · International Journal of Surgery · doi:10.1016/j.ijsu.2005.11.004 · Cited by 4
New Insights and Updates for Established Entities
(2003) · Springer eBooks · doi:10.1007/0-306-47926-5_1 · Cited by 4
Martí, V. H., Sánchez, E. R., Salavert, M., Bosó, V., & Andrés, J. L. P. (2007) · PubMed · Cited by 7
Colouring outside the guidelines
Klompas, M., & Kalil, A. C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.012 · Cited by 4
Hoen, B., Tornos, P., Antunes, M. J., Lekakis, J. P., Lengyel, M., Naber, C. K., & Zamorano, J. L. (2009) · Cited by 3
Garbati, M. A., Tleyjeh, I. M., & Abba, A. A. (2011) · Case Reports in Infectious Diseases · doi:10.1155/2011/981316 · Cited by 3
The surgical treatment of infective endocarditis: An overview
Mestres, C. A., & Miró, J. M. (2006) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-006-0504-1 · Cited by 4
Pallasch, J., Takahashi, M., Taubert, K. A., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Gewitz, H.-S., Tong, D., Steckelberg, J. M., et al. (2007) · Cited by 3
Postpartum culture negative endocarditis: a case report and review of the current guidelines
Ali, O. F., Ratnaraja, N., Nathani, N., Bhabra, M. S., & Varma, C. (2011) · BMJ Case Reports · doi:10.1136/bcr.03.2011.3935 · Cited by 3
Treatment Protocols for Bacterial Endocarditis and Infection of Electrophysiologic Cardiac Devices
Stryjewski, M. E., & Corey, G. R. (2005) · CRC Press eBooks · doi:10.1201/9781420028232-30 · Cited by 4
Bashore, T. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5892-2.00022-2 · Cited by 5
Principes thérapeutiques des infections à staphylocoques Place et limites des molécules classiques
Domart, Y. (2002) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(02)00624-x · Cited by 2
Combination Antimicrobial Therapies
Fong, I. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_13 · Cited by 2
Issues in the management of endocarditis caused by resistant gram-positive organisms
Stryjewski, M. E., Chu, V. H. Y., Cabell, C. H., & Fowler, V. G. (2004) · Current Infectious Disease Reports · doi:10.1007/s11908-004-0049-7 · Cited by 1
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73540-6 · Cited by 3
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01621-8 · Cited by 1
Metadata
- Authors
- Fortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 33
- Issue
- 1
- Pages
- 120-125
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144592242
- Semantic Scholar
- f5a3d69c04b44df6f88c0ed011b8287037b67ff4
- Cited by
- 126
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- right-sided endocarditis, Staphylococcus aureus, drug abusers, short-course antibiotic therapy, cloxacillin, vancomycin, teicoplanin, gentamicin, glycopeptides, combination antibiotic therapy, treatment failure
- MeSH terms
- Adolescent, Adult, Anti-Bacterial Agents, Cloxacillin, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Gentamicins, Glycopeptides, Humans, Male, Prospective Studies, Staphylococcal Infections, Staphylococcus aureus, Substance Abuse, Intravenous, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.